产品展示更多>>
- Nicotinamide-N-oxide 1986-81-8

- Nicotinamide-N-oxide 1986-81-8
Nicotinamide-N-oxide 1986-81-8
产品描述 描述 Nicotinamide N-oxide is recognized as an in vivo metabolite of nicotinamide which is a precurser of nicotinamide-adenine dinucleotide (NAD+) in animals. The enzyme that catalyzes the reduction of nicotinamide N-oxide to nicotinamide in the liver is xanthine oxidase.纯度 >99%储存/保存方法 Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.基本信息 别名 N-氧代yan酰胺;烟碱-N-氧化物外观 白色粉末可溶性/溶解性 Limited solubility生物活性 靶点 Drug MetaboliteIn vitro(体外研究) Nicotinamide is one of the forms of vitamin B3. It is a precursor for nicotinamide adenine dinucleotide, which is best known as an electron carrier in oxidative phosphorylation and as a cofactor for many dehydrogenases. It is metabolized through two enzymatic systems. The first system starts with the methylation of nicotinamide by nicotinamide N-methyltransferase, which can subsequently be oxidized by aldehyde oxidase. The second enzymatic system oxidizes nicotinamide to nicotinamide N-oxide. A series of nicotinamide N-oxides is synthesized and shown to be novel, potent, and selective antagonists of the CXCR2 receptor. Compound 1 has demonstrated potent inhibition of neutrophil chemotaxis (IC50=10 nM). Compound 2 is a selective antagonist of IL-8 binding (IC50=110 nM) and potent inhibitor of neutrophil chemotaxis (IC50=170 nM).参考文献 参考文献 1. Tian YJ, et al. Br J Nutr. 2014 May;111(9):1594-601.
2. Maeta A, et al. Biosci Biotechnol Biochem. 2014;78(8):1306-9.
3. Li D, et al. Br J Nutr. 2013 Dec; 110(12):2156-64.
研究领域 研究领域 Cell CycleCell DivisionSignal TransductionSignaling PathwayG Protein SignalingGPCRMicrobiologyOrganismVirusRNA VirusssRNA positive strand virusSARS CoronavirusDrug DiscoverySmall Molecule DrugLead Compound DiscoveryNicotinamide-N-oxide 1986-81-8温馨提示:本产品仅作科研实验使用,不支持临床等研究
